Table 2. Antibody to B19V and PARV4 and detection of viral DNA in mothers and newborns, Taiwan, 2000–2009*.
Case and patient |
B19V |
|
PARV4 |
||
Antibody |
DNA |
Antibody |
DNA |
||
A | |||||
Mother | IgM+, IgG+; anti-VP1 and 2 | + | IgM+, IgG+ | + | |
Newborn |
IgM–, IgG+; anti-VP1 and 2 |
+ |
|
IgM–, IgG+ |
+ |
B | |||||
Mother | IgM–, IgG+ to VP2 only | – | IgM–, IgG+ | + | |
Newborn |
IgM–, IgG+; to VP2 only |
– |
|
IgM–, IgG+ |
+ |
C | |||||
Mother | IgM–, IgG– | – | IgM weak +, IgG– | + | |
Newborn |
IgM–, IgG– |
– |
|
IgM–, IgG– |
– |
D | |||||
Mother | IgM–, IgG– | – | IgM weakly positive, IgG– | + | |
Newborn |
IgM–, IgG– |
– |
|
IgM–, IgG– |
+ |
E | |||||
Mother |
IgM weakly positive, IgG+, to VP2 only |
– |
|
IgM+, IgG+ |
+ |
F | |||||
Newborn | IgM–, IgG+; to VP2 only | – | IgM–, IgG+ | + |
*B19V, parvovirus B19 virus; PARV4, parvovirus 4; Ig, immunoglobulin; +, positive; VP, viral protein; –, negative.